CA1040619A - Steroids of the androstane series, having anaesthetic activity - Google Patents

Steroids of the androstane series, having anaesthetic activity

Info

Publication number
CA1040619A
CA1040619A CA174,050A CA174050A CA1040619A CA 1040619 A CA1040619 A CA 1040619A CA 174050 A CA174050 A CA 174050A CA 1040619 A CA1040619 A CA 1040619A
Authority
CA
Canada
Prior art keywords
group
beta
hydrogen atom
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA174,050A
Other languages
English (en)
French (fr)
Other versions
CA174050S (en
Inventor
Gordon H. Phillipps
Christopher E. Newall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of CA1040619A publication Critical patent/CA1040619A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CA174,050A 1972-06-15 1973-06-14 Steroids of the androstane series, having anaesthetic activity Expired CA1040619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
CA1040619A true CA1040619A (en) 1978-10-17

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
CA174,050A Expired CA1040619A (en) 1972-06-15 1973-06-14 Steroids of the androstane series, having anaesthetic activity

Country Status (9)

Country Link
BE (1) BE800899R (da)
CA (1) CA1040619A (da)
DE (1) DE2330342A1 (da)
DK (1) DK136157B (da)
FR (1) FR2189034B2 (da)
GB (1) GB1434919A (da)
LU (1) LU67790A1 (da)
NL (1) NL7308267A (da)
ZA (1) ZA734037B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112110976B (zh) 2013-04-17 2023-08-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
SI2986623T1 (sl) 2013-04-17 2019-03-29 Sage Therapeutics, Inc. 19-NOR C3,3-disubstituirani C21-N-pirazolil steroidi in metode njhove uporabe
DK3021852T3 (da) 2013-07-19 2021-03-15 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser deraf
WO2015027227A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2016061537A1 (en) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
SG10202009859YA (en) 2014-10-16 2020-11-27 Sage Therapeutics Inc Compositions and methods for treating cns disorders
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3250210B1 (en) 2015-01-26 2020-12-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP4155314A1 (en) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
IL264129B2 (en) 2016-07-11 2024-05-01 Sage Therapeutics Inc C20, C17 and C21 converted neuroactive steroids and methods of using them
EP3481844B1 (en) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
CR20210629A (es) 2019-05-31 2022-03-22 Sage Therapeutics Inc Esteroides neuroactivos y composiciones de estos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
BE776786A (fr) * 1970-12-17 1972-06-16 Glaxo Lab Ltd Composes de la serie du pregnane et de l'androstane a activite anesthesique
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
FR2189034A2 (da) 1974-01-25
NL7308267A (da) 1973-12-18
DE2330342A1 (de) 1974-01-17
ZA734037B (en) 1974-05-29
DK136157B (da) 1977-08-22
DK136157C (da) 1978-01-23
AU5693773A (en) 1974-12-19
BE800899R (fr) 1973-12-14
GB1434919A (en) 1976-05-12
LU67790A1 (da) 1973-08-16
FR2189034B2 (da) 1977-01-21

Similar Documents

Publication Publication Date Title
US3989686A (en) Anaesthetic steroids of the androstane series and process for preparing same
CA1040619A (en) Steroids of the androstane series, having anaesthetic activity
US3943124A (en) Chemical compounds
US3983111A (en) Steroidal anaesthetics of the pregnane and 19-norpregnane series
US3998829A (en) Steroid anaesthetics of the pregnane and 19-norpregnane series
US4285937A (en) Novel androstadiene-17-carboxylic acid esters
PH25963A (en) Steroid 5-o-reductase inhibitors pharmaceutical composition containing them and process for preparing said compound
CA1051868A (en) D-homo-20-keto-pregnanes
CA1310009C (en) Ester prodrugs of steroids
US3981894A (en) Chemical compounds
US4226862A (en) Steroids and process for preparing the same
US6005124A (en) Method for the preparation of steroid derivative ketal
US3959260A (en) Anaesthetic steroids of the pregnane and 19-norpregnane series having a sulfur-containing group at the 21-position
US3869451A (en) Anaesthetic steroids of the pregnane and 19-norpregnane series
DE2715863A1 (de) Verfahren zur herstellung von steroidcarbonsaeuren und ihren estern
AT363203B (de) Verfahren zur herstellung von neuen 9alpha,21-
US3969345A (en) 20β,21-Epoxy-3α-hydroxy-5α-pregnanes and derivatives thereof
US3882151A (en) Chemical compounds
US3883569A (en) Novel 3{60 -hydroxysteroids of the 5{60 -pregnane series
CA1306743C (en) DOUBLE ESTER OF 16.beta.-ETHYLESTRAN-17.beta.-OL DERIVATIVES
US3952031A (en) Anaesthetic composition containing a steroid of the 5α-pregnane series and method of using same
IL28867A (en) 1-adamantyl and 1-adamantylmethyl carbonates of testosterone and derivatives thereof
US4330540A (en) Ent-16-amino-17-hydroxy-oestra-1,3,5(10)-trienes and derivatives thereof, and pharmaceutical compositions
EP0010320B1 (en) Novel 3-beta-amino-2-beta-hydroxy steroids of the androstane, oestrane and pregnane series, processes for their preparation and pharmaceutical compositions
US4145357A (en) Steroid derivatives and process for preparing the same